TOP TIERMARKET NEWSWIRE
News & sentiment

APNIMED INC (APMD) — News & AI sentiment

APNIMED INC (APMD) news roundup. 5 stories in the past week, 14 over 30 days. Average 30-day sentiment is 59.8/100. Recent insider activity (SEC Form 4, 90-day window): 2 purchases totalling $5.2M and 0 sales totalling $0 — net buying of $5.2M. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
5
avg sentiment 60.4/100
30d stories
14
avg sentiment 59.8/100
Insider net (90d)
$5.2M
2 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

APMD news in the last 24 hours, 7 days, 30 days and 90 days

How much APMD coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowAPMD storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days560.4/100APMD headlines →
Last 30 days1459.8/100APMD headlines →
Last 90 days3552.8/100APMD headlines →

Latest stories on APMD

Apnimed: What We Know Heading Into The Feb PDUFA
Seeking Alpha76 · bullishproduct/pr
3d ago
Apnimed, Inc. (APMD) files 8-K
SEC 8-K50 · neutralgeneral
5d ago
Apnimed, Inc. reports Q2 results
Seeking Alpha50 · neutralearnings
5d ago
5d ago
5d ago
Sep 4
Sep 4
Apnimed rises on Street initiations following IPO
Seeking Alpha67 · bullishanalyst
Aug 25
Cantor Fitzgerald initiates Apnimed stock with overweight rating
Investing.com Analyst Ratings61 · neutralanalyst
Aug 25
BofA initiates Apnimed stock with buy rating on sleep apnea drug
Investing.com Analyst Ratings61 · neutralanalyst
Aug 25
Aug 25
Aug 25
Aug 25
Apnimed initiated with a Buy at BofA
The Fly61 · neutralanalyst
Aug 25
Best-performing 2026 U.S. IPOs: Apnimed leads with a 65.7% gain
Investing.com Markets73 · bullishearnings
Aug 5
Apnimed raises $220.8M in upsized Nasdaq IPO
Investing.com Markets24 · bearishgeneral
Aug 3
Aug 3
APMD Trading Strategies for Apnimed Stock
Barchart55 · neutralanalyst
Aug 3
APMD Insider Trades for Apnimed Stock
Barchart50 · neutralgeneral
Aug 3
Sleep drug developer Apnimed rises on trading debut
Seeking Alpha63 · neutralearnings
Jul 31
Jul 31
Jul 31
APMD Barchart Opinion for Apnimed Stock
Barchart56 · neutralanalyst
Jul 31
Jul 31
Apnimed prices IPO at $16 per share, raising $192 million
Investing.com Markets28 · bearishgeneral
Jul 31
Open APMD in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →